439 related articles for article (PubMed ID: 25881001)
1. Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders.
Parenti G; Andria G; Valenzano KJ
Mol Ther; 2015 Jul; 23(7):1138-1148. PubMed ID: 25881001
[TBL] [Abstract][Full Text] [Related]
2. Personalized Pharmacoperones for Lysosomal Storage Disorder: Approach for Next-Generation Treatment.
Haneef SA; Doss CG
Adv Protein Chem Struct Biol; 2016; 102():225-65. PubMed ID: 26827607
[TBL] [Abstract][Full Text] [Related]
3. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics.
Parenti G
EMBO Mol Med; 2009 Aug; 1(5):268-79. PubMed ID: 20049730
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in therapeutic approaches for lysosomal storage diseases.
Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
[TBL] [Abstract][Full Text] [Related]
5. New strategies for the treatment of lysosomal storage diseases (review).
Parenti G; Pignata C; Vajro P; Salerno M
Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
[TBL] [Abstract][Full Text] [Related]
6. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
Thomas R; Kermode AR
Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological chaperone therapy for lysosomal storage diseases.
Parenti G; Moracci M; Fecarotta S; Andria G
Future Med Chem; 2014 Jun; 6(9):1031-45. PubMed ID: 25068986
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.
Valenzano KJ; Khanna R; Powe AC; Boyd R; Lee G; Flanagan JJ; Benjamin ER
Assay Drug Dev Technol; 2011 Jun; 9(3):213-35. PubMed ID: 21612550
[TBL] [Abstract][Full Text] [Related]
9. A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders.
Pastores GM; Sathe S
Drugs R D; 2006; 7(6):339-48. PubMed ID: 17073517
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal storage diseases: from pathophysiology to therapy.
Parenti G; Andria G; Ballabio A
Annu Rev Med; 2015; 66():471-86. PubMed ID: 25587658
[TBL] [Abstract][Full Text] [Related]
11. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.
Fan JQ
Biol Chem; 2008 Jan; 389(1):1-11. PubMed ID: 18095864
[TBL] [Abstract][Full Text] [Related]
12. Treatments for lysosomal storage disorders.
Lachmann R
Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
[TBL] [Abstract][Full Text] [Related]
13. [Lysosomes and lysosomal storage diseases].
Germain DP
J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate-Processing Enzymes of the Lysosome: Diseases Caused by Misfolded Mutants and Sugar Mimetics as Correcting Pharmacological Chaperones.
Stütz AE; Wrodnigg TM
Adv Carbohydr Chem Biochem; 2016; 73():225-302. PubMed ID: 27816107
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Boyd RE; Lee G; Rybczynski P; Benjamin ER; Khanna R; Wustman BA; Valenzano KJ
J Med Chem; 2013 Apr; 56(7):2705-25. PubMed ID: 23363020
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for lysosomal storage disorders: developing insights.
van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lysosomal storage diseases: recent patents and future strategies.
Ortolano S; Viéitez I; Navarro C; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
[TBL] [Abstract][Full Text] [Related]
18. Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses.
Losada Díaz JC; Cepeda Del Castillo J; Rodriguez-López EA; Alméciga-Díaz CJ
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905715
[TBL] [Abstract][Full Text] [Related]
19. Update on treatment of lysosomal storage diseases.
Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV
Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy.
Beck M
Hum Genet; 2007 Mar; 121(1):1-22. PubMed ID: 17089160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
